TELA Bio, Inc. Cash and Restricted Cash
TELA Bio, Inc. (TELA) had Cash and Restricted Cash of $30.62 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30.62M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $39.79M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $51.09M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29.96M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $30.62M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $39.79M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $51.09M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $29.96M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $35.24M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $43.10M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $52.94M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $17.57M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $26.76M 10-Q · filed 2025-08-11 |
| 2024-03-31 | $37.41M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $46.99M 10-K · filed 2026-03-25 |
| 2023-09-30 | $58.20M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $65.27M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $30.12M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $42.02M 10-K · filed 2026-03-25 |
| 2022-09-30 | $54.23M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $27.73M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $33.02M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $43.93M 10-K · filed 2025-03-21 |
| 2021-09-30 | $53.64M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $60.29M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $65.83M 10-Q · filed 2022-05-11 |
| 2020-12-31 | $74.39M 10-K · filed 2024-03-22 |
| 2020-09-30 | $81.47M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $85.47M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $41.41M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $45.30M 10-K · filed 2023-03-23 |
| 2019-09-30 | $10.70M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $15.87M 10-Q · filed 2020-08-13 |
| 2019-03-31 | $9.43M 10-Q · filed 2020-05-15 |
| 2018-12-31 | $17.28M 10-K · filed 2022-03-23 |
| 2018-09-30 | $1.91M 10-Q · filed 2019-12-18 |
| 2017-12-31 | $11.35M 10-K · filed 2021-03-25 |
| 2016-12-31 | $1.48M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |